Xiaofeng Ding

1.3k total citations
42 papers, 974 citations indexed

About

Xiaofeng Ding is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaofeng Ding has authored 42 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xiaofeng Ding's work include MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and RNA modifications and cancer (6 papers). Xiaofeng Ding is often cited by papers focused on MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and RNA modifications and cancer (6 papers). Xiaofeng Ding collaborates with scholars based in China, United States and Macao. Xiaofeng Ding's co-authors include Shuanglin Xiang, Xiang Hu, Jianlin Zhou, Chang Zhou, Xing Zhang, Meilian Liu, Xin Yang, Yan Luo, Yuzhong Xiao and Xuexian O. Yang and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaofeng Ding

39 papers receiving 968 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Xiaofeng Ding	589	297	159	143	142	42	974
Peng Yuan	653 1.1×	391 1.3×	136 0.9×	129 0.9×	97 0.7×	33	1.1k
Zhiqin Xie	816 1.4×	285 1.0×	144 0.9×	91 0.6×	76 0.5×	58	1.2k
Kamala Sundararaj	602 1.0×	174 0.6×	128 0.8×	217 1.5×	144 1.0×	26	1.1k
Huanbai Xu	558 0.9×	240 0.8×	146 0.9×	184 1.3×	87 0.6×	33	1.0k
Kayleigh Dodd	554 0.9×	152 0.5×	132 0.8×	82 0.6×	156 1.1×	10	839
Thomas C. Raissi	637 1.1×	295 1.0×	187 1.2×	375 2.6×	158 1.1×	6	1.1k
Xueli Pang	547 0.9×	324 1.1×	216 1.4×	189 1.3×	109 0.8×	27	1.0k
Su Myung Jung	451 0.8×	148 0.5×	171 1.1×	165 1.2×	234 1.6×	27	870
Delphine Gitenay	455 0.8×	142 0.5×	77 0.5×	111 0.8×	127 0.9×	22	761
Yuri Ivashchenko	953 1.6×	336 1.1×	105 0.7×	193 1.3×	180 1.3×	17	1.4k

Countries citing papers authored by Xiaofeng Ding

Since Specialization

Citations

This map shows the geographic impact of Xiaofeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Ding more than expected).

Fields of papers citing papers by Xiaofeng Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Ding. The network helps show where Xiaofeng Ding may publish in the future.

Co-authorship network of co-authors of Xiaofeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Ding. A scholar is included among the top collaborators of Xiaofeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Ding. Xiaofeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Chen, Hanbin Chen, Xiaofeng Ding, et al.. (2025). METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression. Cell Death and Disease. 16(1). 9–9. 4 indexed citations

Zhao, Yingchao, Jiangwei Lu, Xinyue Zhang, et al.. (2025). Biological and Bioinspired Vesicles for Wound Healing: Insights, Advances and Challenges. International Journal of Nanomedicine. Volume 20. 8497–8528.

Ding, Xiaofeng, et al.. (2025). Integrating bioinformatics and metabolomics to identify potential biomarkers of hypertensive nephropathy. Scientific Reports. 15(1). 7437–7437. 1 indexed citations

Golden, Alyssa, Gregory J. Tyrrell, Julianne V. Kus, et al.. (2024). Invasive Group A Streptococcus Hypervirulent M1_UK Clone, Canada, 2018–2023. Emerging infectious diseases. 30(11). 2409–2413. 4 indexed citations

Zheng, Xiuli, Jun An, Hua Yang, et al.. (2023). P2.09-36 Efficacy and Safety of Furmonertinib 160 mg as First-line Therapy for EGFR-mutated Advanced NSCLC Patients with CNS Metastases. Journal of Thoracic Oncology. 18(11). S348–S348. 1 indexed citations

Huang, Gui‐Xiang, Mi Ouyang, Kai Xiao, et al.. (2023). Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression. Cell Death and Disease. 14(6). 365–365. 21 indexed citations

Wang, Chunqing, Xing Zhang, Liping Luo, et al.. (2022). Adipocyte-derived PGE2 is required for intermittent fasting–induced Treg proliferation and improvement of insulin sensitivity. JCI Insight. 7(5). 19 indexed citations

Wang, Lu, Yan Luo, Liping Luo, et al.. (2020). Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling. The Journal of Experimental Medicine. 218(2). 46 indexed citations

Xiao, Ye, Xiaofeng Ding, Yi Sun, et al.. (2020). Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. EBioMedicine. 51. 102603–102603. 34 indexed citations

10.

Zhang, Xing, Dandan Wu, Chunqing Wang, et al.. (2019). Sustained activation of autophagy suppresses adipocyte maturation via a lipolysis-dependent mechanism. Autophagy. 16(9). 1668–1682. 36 indexed citations

11.

Yang, Liu, Yuzhong Xiao, Xiang Hu, et al.. (2018). AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition. Theranostics. 8(13). 3707–3721. 27 indexed citations

12.

Chen, Cheng, Wenhuan Huang, Xinxin Li, et al.. (2014). Eps8 regulates cellular proliferation and migration of breast cancer. International Journal of Oncology. 46(1). 205–214. 36 indexed citations

13.

Zhang, Xiaoting, Xiaofeng Li, Xiaofeng Ding, et al.. (2013). MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. Oncology Letters. 6(5). 1427–1434. 31 indexed citations

14.

Ding, Xiaofeng, Fangliang Zhou, Xinxin Li, et al.. (2013). Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression. The International Journal of Biochemistry & Cell Biology. 45(8). 1647–1656. 26 indexed citations

15.

Ding, Xiaofeng, Fangliang Zhou, Chang Zhou, et al.. (2012). Eps8 promotes cellular growth of human malignant gliomas. Oncology Reports. 29(2). 697–703. 22 indexed citations

16.

Hu, Xiang, Feng Yan, Ling Xiao, et al.. (2012). TNFAIP1 interacts with KCTD10 to promote the degradation of KCTD10 proteins and inhibit the transcriptional activities of NF-κB and AP-1. Molecular Biology Reports. 39(11). 9911–9919. 17 indexed citations

17.

Wu, Yuan, Yuzhong Xiao, Xiaofeng Ding, et al.. (2011). A miR-200b/200c/429-Binding Site Polymorphism in the 3′ Untranslated Region of the AP-2α Gene Is Associated with Cisplatin Resistance. PLoS ONE. 6(12). e29043–e29043. 72 indexed citations

18.

Ding, Xiaofeng, et al.. (2009). Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells. BMC Cancer. 9(1). 279–279. 24 indexed citations

19.

Wang, Yan, et al.. (2008). Differential gene expression profiling of human epidermal growth factor receptor 2-overexpressing mammary tumor. Acta Biochimica et Biophysica Sinica. 40(5). 397–405. 4 indexed citations

20.

Ding, Xiaofeng, Chang Luo, Jianlin Zhou, et al.. (2008). The interaction of KCTD1 with transcription factor AP‐2α inhibits its transactivation. Journal of Cellular Biochemistry. 106(2). 285–295. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact